Literature DB >> 12040764

Uropathogenic Escherichia coli causing urinary tract infections.

P Mandal1, A Kapil, K Goswami, B Das, S N Dwivedi.   

Abstract

BACKGROUND &
OBJECTIVES: The information on the characteristics of Escherichia coli causing urinary tract infections is limited. We have characterised the urovirulence factors of Esch. coli isolated from symptomatic patients of urinary tract infections (UTI) in order to determine their pathogenic potential and the antibiotic sensitivity profile.
METHODS: Semi-quantitative urine culture was done on 370 symptomatic patients suffering from urinary tract infections. Phenotypic characterization of the urovirulence factors of Esch. coli was undertaken and the antibiotic susceptibility was determined.
RESULTS: Esch. coli was responsible for 45.5 per cent of infections. Resistance to amoxycillin, cotrimoxazole, nalidixic acid, norfloxacin and ciprofloxacin among Esch. coli isolates ranged from 70-95 per cent. Serotype O101 was found to be the commonest serotype (7/26). The virulence factors associated with uropathogenic Esch. coli were haemolysin production (5/30), presence of mannose resistant P-fimbriae (5/30), presence of mannose sensitive type 1 fimbriae (6/30) and the presence of mannose resistant F-fimbriae (2/30). Siderophores production was seen in all the isolates causing UTI. INTERPRETATION &
CONCLUSION: Esch. coli was found to be the commonest cause of UTI in our study population. Antibiotic resistance was high among the strains circulating which emphasises the need for judicious use of antibiotics. Certain virulence factors like haemolysin production and presence of fimbriae in the Esch. coli may be associated with the urovirulence.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12040764

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  5 in total

1.  Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia.

Authors:  W V Kern; K Klose; A S Jellen-Ritter; M Oethinger; J Bohnert; P Kern; S Reuter; H von Baum; R Marre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

2.  Phenotypic study of virulence factors in Escherichia coli isolated from antenatal cases, catheterized patients, and faecal flora.

Authors:  Shruthi N; Ravi Kumar; Ravish Kumar
Journal:  J Clin Diagn Res       Date:  2012-10-26

3.  Prevalence of antimicrobial resistance in fecal generic Escherichia coil isolated in western Canadian cow-calf herds. Part I--beef calves.

Authors:  Sheryl P Gow; Cheryl L Waldner; Andrijana Rajić; Margaret E McFall; Richard Reid-Smith
Journal:  Can J Vet Res       Date:  2008       Impact factor: 1.310

4.  A Clinical Extensively-Drug Resistant (XDR) Escherichia coli and Role of Its β-Lactamase Genes.

Authors:  Mingyu Wang; Wenjia Wang; Yu Niu; Ting Liu; Ling Li; Mengge Zhang; Ziyun Li; Wenya Su; Fangyue Liu; Xuhua Zhang; Hai Xu
Journal:  Front Microbiol       Date:  2020-12-10       Impact factor: 5.640

5.  Clonal spread of Escherichia coli O101: H9-ST10 and O101: H9-ST167 strains carrying fosA3 and bla CTX-M-14 among diarrheal calves in a Chinese farm, with Australian Chroicocephalus as the possible origin of E. coli O101: H9-ST10.

Authors:  Wan-Yun He; Xing-Xing Zhang; Guo-Long Gao; Ming-Yi Gao; Fa-Gang Zhong; Lu-Chao Lv; Zhong-Peng Cai; Xing-Feng Si; Jun Yang; Jian-Hua Liu
Journal:  Zool Res       Date:  2021-07-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.